These results motivated us to investigate whether DDA1 participates in lung cancer tumorigenesis and tumour progression through the regulation of cyclins and cell cycle progression and thus could serve as a prognostic biomarker for lung cancer. The gene discussed is PCNA; the disease is neoplasm.